Citigroup Reports Strong 2025 Earnings, Significantly Increases Share Repurchases, and Achieves Key Regulatory Milestones
Summary
Citigroup reported strong 2025 earnings with a 13% rise in net income and a significant increase in share repurchases to $13.3 billion. The company also achieved a major regulatory milestone with the termination of an OCC Consent Order amendment and completed its Russia exit, which is expected to boost Q1 2026 capital.
Key Events
-
Strong 2025 Financial Performance
Citigroup reported net income of $14.3 billion, a 13% increase from the prior year, with diluted earnings per share rising 17.7% to $6.99. Revenues increased by 6% to $85.2 billion, demonstrating positive operating leverage.
-
Significant Capital Return to Shareholders
The company returned $17.6 billion to common shareholders, including $13.3 billion in share repurchases, a substantial increase from $2.5 billion in 2024, and $4.3 billion in dividends.
-
Key Regulatory Milestone Achieved
Citigroup advanced its multiyear transformation, with over 80% of programs nearing completion. Notably, the OCC terminated its July 2024 amendment to Citibank's 2020 Consent Order in December 2025.
-
Russia Exit Completed with Future Capital Benefit
The sale of AO Citibank in Russia closed on February 18, 2026, following a $1.2 billion pre-tax loss on sale in Q4 2025. This divestiture is expected to provide an estimated $4 billion benefit to CET1 capital in Q1 2026.
Analysis
Citigroup delivered robust financial results for 2025, marked by a substantial increase in net income and diluted EPS, alongside a significant boost in capital returns to shareholders. The company repurchased $13.3 billion in common shares, a sharp increase from the prior year, demonstrating a strong commitment to shareholder value. Operationally, Citigroup made considerable progress on its multiyear transformation, culminating in the termination of a key OCC Consent Order amendment in December 2025, a major regulatory achievement. The completed sale of AO Citibank in Russia, though resulting in a Q4 2025 pre-tax loss, is expected to provide a $4 billion benefit to CET1 capital in Q1 2026. While capital ratios saw a slight decrease, they remain above regulatory requirements, and the early adoption of a revised eSLR rule is a favorable development for future capital management. The goodwill impairment related to the Banamex sale is a notable one-off charge as part of the ongoing strategic divestiture.
At the time of this filing, C was trading at $116.00 on NYSE in the Finance sector, with a market capitalization of approximately $207.6B. The 52-week trading range was $55.51 to $125.16. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.